Breast Implant Rupture: Understanding Changes, Scans and Next Steps

Breast implant rupture means a tear or hole in an implant’s outer shell. A saline implant usually loses volume as its saltwater filling leaks out, while a silicone gel implant can rupture without an obvious change in appearance or feel. If you notice a new breast change, contact your surgeon or another healthcare professional rather than trying to diagnose the implant yourself. Assessment may involve an examination, your device records and imaging selected for the problem being investigated.

1. How Do Saline and Silicone Implant Ruptures Differ?

Both saline-filled and silicone gel-filled breast implants have silicone outer shells. Their fillings behave differently when that shell fails. This is why a visible loss of breast volume and a silent change found on a scan can both lead to an implant assessment.

1.1 Deflation Describes a Saline Implant Losing Volume

Deflation refers to the partial or complete collapse of a saline implant as filling leaks out. It can follow a shell tear or a valve leak. The change may develop quickly or over several days. The body absorbs the saline, but this does not repair the device or remove its shell. A newly deflated implant still needs assessment.

1.2 Silicone Rupture May Remain Contained

The body forms a scar-tissue envelope, called a capsule, around an implant. An intracapsular rupture means silicone has escaped the implant shell but remains within that capsule. An extracapsular rupture means silicone has extended beyond the capsule. These terms describe where the gel is located, not how much pain someone should feel. Silicone that has spread into surrounding tissues may be difficult to remove completely.

2. What Can Symptoms Tell You About Rupture?

Possible changes include altered breast size or shape, new unevenness, lumps, swelling, tenderness, hardening or altered sensation. However, these findings do not establish the cause. A useful assessment asks both whether the implant is intact and whether another breast or implant-related problem needs investigation.

Pain does not prove rupture, and a lack of pain does not exclude it. A silent rupture is one that produces no noticeable symptoms or visible change. An examination alone may not detect it. Equally, discomfort deserves attention even when an implant has not visibly changed.

Hardening can also occur with capsular contracture, meaning tightening of the scar tissue around an implant. Fluid collections, infection and implant movement are other recognised complications. Their possible overlap is a reason to describe the change clearly rather than arrive at an appointment certain that rupture is the explanation.

2.1 Describe What Changed Rather Than Testing the Implant

Before an appointment, consider writing down when you first noticed the problem, whether it affects one or both breasts, and whether it is changing. Note any recent injury, operation or previous implant replacement. Bring existing imaging reports if available. These details give the clinician a clearer starting point without asking you to interpret a scan or determine the diagnosis.

You do not need to identify a tear, distinguish the capsule from the shell or reproduce a symptom before seeking help. The purpose of the appointment is to resolve uncertainty, not to confirm a conclusion you have already reached.

3. Imaging for a New Change Is Different From Routine Surveillance

Two separate questions often become confused: checking an implant when someone has no symptoms, and investigating a new symptom or examination finding. The first is surveillance. The second is diagnostic evaluation. A future surveillance appointment is not a reason to postpone reporting a new change.

3.1 Surveillance Uses Current Device Guidance

In the United States, silicone implant patient labelling commonly recommends a first ultrasound or magnetic resonance imaging scan, usually called MRI, five to six years after implantation, followed by imaging every two to three years. This schedule is stated in the FDA-listed patient labelling consulted for this article.

That is a surveillance schedule for people without symptoms, not a waiting period before a suspected problem can be investigated. Your clinician should check the current labelling for your actual implant and applicable local recommendations. Older paperwork or an online schedule for a different product should not automatically determine your follow-up.

The FDA’s approved-implant labelling index distinguishes original documents from current patient information. This matters because device information can change after approval. Ask which version applies to your implant, particularly if it was inserted years ago or in another country.

3.2 Diagnostic Imaging Answers a Specific Clinical Question

For suspected silicone rupture, MRI is particularly useful for identifying a rupture contained within the surrounding capsule. Implant-integrity MRI generally does not require intravenous contrast, the injected material used for some other MRI examinations. Ultrasound is also used in implant assessment and is an accepted surveillance alternative for asymptomatic silicone implants.

If symptoms suggest silicone rupture or ultrasound findings are uncertain, the consulted device labelling recommends MRI. The clinician and radiologist should decide which examination answers the question. A request to assess implant integrity is not necessarily the same as a request to investigate a breast lump, fluid collection or possible cancer.

For suspected saline rupture, examination may make deflation apparent. When imaging is needed, the choice can depend on age and the clinical findings. It is therefore reasonable for different people with suspected implant problems to receive different imaging recommendations.

3.3 A Normal Mammogram Does Not Exclude Rupture

Mammography is not a reliable way to exclude a contained silicone rupture. A normal mammogram should not be interpreted as proof that the implant shell is intact. Conversely, an implant check does not replace breast cancer screening or the investigation of a new breast symptom.

Continue the breast screening appropriate to your circumstances and tell the imaging service that you have implants. If you have had previous silicone implants removed or replaced, mention that history too: silicone seen on imaging can sometimes relate to an earlier implant rather than a rupture of the current one. Previous images can help clarify the findings.

4. Which Records Help With Assessment?

Your implant card and operation records can help identify the device and locate its current patient information. If you have them, bring them rather than relying on memory. Useful details to gather include:

• The manufacturer and implant model
• Whether the filling is saline or silicone gel
• The implantation date and any later replacement dates
• Device identification or serial numbers
• The surgeon or hospital where treatment took place
• Previous scan reports and, where available, the images themselves

If the records are missing, tell the assessing clinician. You can ask the original surgeon or hospital whether copies remain available, but do not delay reporting symptoms while searching for paperwork. At the appointment, ask which missing information is important and who can help obtain it.

Keep a copy of the assessment outcome as well. A useful written plan should make clear what was found, whether further testing is needed, who will arrange it and how you will receive the results. This is especially helpful when the surgeon and imaging service work in different organisations.

5. What Happens if Rupture Is Confirmed?

A confirmed rupture calls for a discussion with a surgeon about the device, imaging findings and management options. The consulted silicone implant patient labelling recommends removal of a ruptured implant, with replacement or no replacement considered according to medical needs and preferences. Confirmation does not, by itself, establish a universal deadline for every person.

Ask the treating team to explain the recommended timing for your situation. The conversation should distinguish what the scan demonstrates, what remains uncertain and what the proposed operation is intended to address. If there is disagreement between an examination and a scan report, ask how that discrepancy will be resolved before decisions are made.

5.1 Removal, Replacement and Capsule Surgery Are Separate Decisions

Implant removal does not automatically mean replacement. Similarly, removing an implant and removing surrounding scar tissue are separate surgical decisions. Capsule surgery may involve removing part or all of that tissue, and more extensive dissection can carry additional risks, including bleeding.

Discuss the expected benefit and limitations of each part of the proposed procedure. Relevant questions include the risks of surgery and anaesthesia, possible changes in breast appearance, whether silicone outside the implant can be removed, and what follow-up would be needed afterward. No further operation can guarantee a particular appearance or freedom from future complications.

5.2 Questions to Take to the Consultation

• Is rupture confirmed, suspected or still uncertain?
• If silicone has escaped, where does the imaging show it?
• Does another finding need investigation before surgery is planned?
• What are the benefits and risks of removal with or without replacement?
• Why is capsule removal being recommended, and how extensive would it be?
• What timing do you recommend, and what should prompt earlier contact?
• Who will coordinate results, treatment and subsequent follow-up?

6. New Changes That Need Prompt Assessment

Contact your surgeon or another healthcare professional promptly about a new loss of breast volume, persistent swelling, a lump, ongoing pain, hardening or a change in implant position or shape. Also report nipple discharge, skin dimpling or an injury to the breast. Do not assume that a change years after surgery is simply an expected feature of an older implant.

Persistent swelling, a mass or pain around an implant can have causes other than rupture. One uncommon but important consideration is breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, a cancer of the immune system associated more strongly with textured implants. These symptoms do not mean someone has lymphoma, but they warrant evaluation rather than an assumption about leakage.

If you suspect infection or feel acutely unwell, seek urgent medical advice rather than waiting for a routine implant appointment. A symptom list cannot identify every complication or safely exclude a serious problem.

The practical next step is an individual assessment, not self-diagnosis. Ask for a clear explanation of what is known, which test or consultation comes next and how urgently it should happen. That approach keeps silent device changes, new symptoms and treatment decisions in their proper context.